IBD Biologics After COVID; Cutting Endoscopy Waste; New Humira Biosimilar OK'd

(MedPage Today) -- How soon after a COVID-19 infection is it OK to administer biologics for patients with inflammatory bowel disease (IBD)? (Clinical Gastroenterology and Hepatology) Compared with second-dose side effects, gastrointestinal symptoms...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news